Spots Global Cancer Trial Database for androgen deprivation
Every month we try and update this database with for androgen deprivation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM) | NCT02057939 | Prostate Cancer | enzalutamide Androgen Depriv... Radiation Thera... | 18 Years - | Duke University | |
| A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer | NCT01685983 | Prostate Cancer | Abiraterone ace... Prednisolone | 18 Years - | Janssen Research & Development, LLC | |
| A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer | NCT05100472 | Prostate Cancer | Androgen depriv... Brachytherapy Hypofractionate... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Effect of Soy on Cognition and Hot Flashes in Men With Prostate Cancer Undergoing Testosterone Suppression Therapy | NCT00245518 | Hot Flashes | Isoflavone Placebos | 21 Years - | Johns Hopkins University | |
| RADAR Trial - Randomised Androgen Deprivation and Radiotherapy | NCT00193856 | Prostate Cancer | Leuprorelin Ace... Zoledronic Acid Conventional ex... | 18 Years - | Trans Tasman Radiation Oncology Group | |
| A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy | NCT03043807 | Prostate Cancer | Leuprolide Acet... Docetaxel Bicalutamide Radiation Abiraterone Ace... | 18 Years - 80 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer | NCT01685983 | Prostate Cancer | Abiraterone ace... Prednisolone | 18 Years - | Janssen Research & Development, LLC | |
| Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate Cancer | NCT00658697 | Prostate Cancer | Docetaxel Bevacizumab ADT Bicalutamide | 18 Years - | Dana-Farber Cancer Institute | |
| Safety Study of Pelvic and Prostatic SIB-IMRT With Long-term Androgen Deprivation for High Risk Localized Prostate Cancer | NCT01704027 | Prostate Cancer | Simultaneous in... Androgen depriv... | 18 Years - 85 Years | Centre Georges Francois Leclerc | |
| Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT) | NCT01006395 | Prostate Cancer | Zoledronic acid Placebo | 18 Years - 75 Years | Austin Health | |
| Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM) | NCT02057939 | Prostate Cancer | enzalutamide Androgen Depriv... Radiation Thera... | 18 Years - | Duke University | |
| Androgen Deprivation Therapy in Advanced Salivary Gland Cancer | NCT01969578 | Salivary Gland ... | bicalutamide + ... Cisplatin + Dox... Carboplatin + P... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate | NCT02064036 | Adenocarcinoma ... | Stereotactic Ra... Casodex Leuprolide | 18 Years - | University of California, Davis | |
| Impact of Radical Prostatectomy as Primary Treatment in Patients With Prostate Cancer With Limited Bone Metastases | NCT02454543 | Prostate Cancer | Radical prostat... Best systemic t... | 18 Years - 75 Years | Martini-Klinik am UKE GmbH | |
| Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate Cancer | NCT01717053 | Prostate Cancer | Abiraterone ace... Androgen depriv... Radiation Thera... Prednisone | 18 Years - | Duke University | |
| Safety Study of Pelvic and Prostatic SIB-IMRT With Long-term Androgen Deprivation for High Risk Localized Prostate Cancer | NCT01704027 | Prostate Cancer | Simultaneous in... Androgen depriv... | 18 Years - 85 Years | Centre Georges Francois Leclerc | |
| Impact of Radical Prostatectomy as Primary Treatment in Patients With Prostate Cancer With Limited Bone Metastases | NCT02454543 | Prostate Cancer | Radical prostat... Best systemic t... | 18 Years - 75 Years | Martini-Klinik am UKE GmbH | |
| Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT) | NCT01006395 | Prostate Cancer | Zoledronic acid Placebo | 18 Years - 75 Years | Austin Health |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
